Adam Havey, EVP, Biodefense Divison at Emergent BioSolutions Inc. (EBS), sold 22,838 shares at $28.62 ($654K) on 2017-04-03, disclosed to the SEC on 2017-04-04.
Open-market sale of $654k EBS by EVP, Biodefense Divison. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.62 | 11,419 | $327K | 50.0% |
| 2 | $28.62 | 11,419 | $327K | 50.0% |
| Total | $28.62 avg | 22,838 | $654K | 100% |
| Filing → |
| EBS | SELL | 2020-04-08 | $478K | — | Filing → |
| EBS | SELL | 2019-03-13 | $277K | — | Filing → |
| EBS | SELL | 2019-03-04 | $354K | — | Filing → |